Kezar Life Sciences Inc. (NASDAQ: KZR) Stock Information | RedChip

Kezar Life Sciences Inc. (NASDAQ: KZR) Listen to this Section


$0.61
-0.0099 ( -1.59% ) 188.6K

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Market Data


Open


$0.61

Previous close


$0.62

Volume


188.6K

Market cap


$44.76M

Day range


$0.61 - $0.64

52 week range


$0.54 - $1.69

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 12 Aug 14, 2023
10-q Quarterly Reports 74 Aug 10, 2023
8-k 8K-related 13 Aug 10, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.